Latest Articles
Aberdeenshire woman makes plea for help as viral chronic illness clothing brand faces closure - Aberdeen Live
Aberdeenshire woman makes plea for help as viral chronic illness clothing brand faces closure Aberdeen Live
Published: Sept. 24, 2026, 2:52 p.m.
Aberdeenshire woman makes plea for help as viral chronic illness clothing brand faces closure - aberdeenlive.news
Aberdeenshire woman makes plea for help as viral chronic illness clothing brand faces closure aberdeenlive.news
Published: Sept. 24, 2026, 2:48 p.m.
Absci Corporation Announces Preliminary Details for Phase 2 Storyline? Trial of Ai-Designed Antibody Abs-201? for Endometriosis - marketscreener.com
Absci Corporation Announces Preliminary Details for Phase 2 Storyline? Trial of Ai-Designed Antibody Abs-201? for Endometriosis marketscreener.com
Published: Sept. 24, 2026, 1:52 p.m.
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 - Investing.com
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 Investing.com
Published: Sept. 24, 2026, 12:51 p.m.
UF’s ECE’s Laura Kim Gets NIH Grant For Quantum Endometriosis Study - quantumzeitgeist.com
UF’s ECE’s Laura Kim Gets NIH Grant For Quantum Endometriosis Study quantumzeitgeist.com
Published: Sept. 24, 2026, 12:37 p.m.
Cleveland Clinic Weston Hospital Welcomes Colorectal Surgeon - South Florida Hospital News
Cleveland Clinic Weston Hospital Welcomes Colorectal Surgeon South Florida Hospital News
Published: Sept. 24, 2026, 12:23 p.m.
Absci Expects to Initiate Mid-Stage Trial of ABS-201 for Endometriosis in Mid-2027 - Yahoo Finance
Absci Expects to Initiate Mid-Stage Trial of ABS-201 for Endometriosis in Mid-2027 Yahoo Finance
Published: Sept. 24, 2026, 12:18 p.m.
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis - The Manila Times
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis The Manila Times
Published: Sept. 24, 2026, 12:10 p.m.
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis - manilatimes.net
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis manilatimes.net
Published: Sept. 24, 2026, 12:10 p.m.
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 - Investing.com UK
Absci plans phase 2 trial of ABS-201 for endometriosis in 2027 Investing.com UK
Published: Sept. 24, 2026, 12:06 p.m.
Link copied to clipboard!